No. |
Product Name |
CAS No. |
Spec |
Price |
|
| LP-7033 |
Primaquine phosphate ≥98% |
63-45-6 |
| 5 g |
Inquiry |
| 10 g |
Inquiry |
| 50 g |
Inquiry |
|
|
| LP-6956 |
Prostaglandin E1 ≥98% |
745-65-3 |
| 1 mg |
Inquiry |
| 5 mg |
Inquiry |
| 10 mg |
Inquiry |
|
|
| LP-6959 |
Prothionamide ≥98% |
14222-60-7 |
| 1 g |
Inquiry |
| 5 g |
Inquiry |
| 25 g |
Inquiry |
|
|
| LR-0249 |
Ramipril ≥98% |
87333-19-5 |
| 500 mg |
Inquiry |
| 1 g |
Inquiry |
| 5 g |
Inquiry |
|
|
| LR-0154 |
Ranolazine Dihydrochloride ≥98% |
95635-56-6 |
| 100 mg |
Inquiry |
| 500 mg |
Inquiry |
| 1 g |
Inquiry |
|
|
| LR-1806 |
Rebamipide ≥98% |
90098-04-7 |
| 1 g |
Inquiry |
| 5 g |
Inquiry |
| 25 g |
Inquiry |
|
|
| LR-2917 |
Rhein 0.88 |
478-43-3 |
| 100 mg |
Inquiry |
| 500 mg |
Inquiry |
| 1 g |
Inquiry |
|
|
| LR-3310 |
Ricobendazole ≥98% |
54029-12-8 |
| 10 g |
Inquiry |
| 25 g |
Inquiry |
| 100 g |
Inquiry |
|
|
| LR-3321 |
Rifaximin ≥98% |
80621-81-4 |
| 500 mg |
Inquiry |
| 1 g |
Inquiry |
| 5 g |
Inquiry |
|
|
| LR-5992 |
Roxithromycin 0.96 |
80214-83-1 |
| 1 g |
Inquiry |
| 5 g |
Inquiry |
| 10 g |
Inquiry |
|
|
| LR-8122 |
Rufloxacin hydrochloride ≥98% |
106017-08-7 |
| 25 mg |
Inquiry |
| 100 mg |
Inquiry |
| 500 mg |
Inquiry |
|
|
| LS-0032 |
Saikosaponin B1 ≥98% |
58558-08-0 |
| 1 mg |
Inquiry |
| 5 mg |
Inquiry |
|
|
| LS-0033 |
Saikosaponin B2 ≥98% |
|
| 1 mg |
Inquiry |
| 5 mg |
Inquiry |
|
|
| LS-0046 |
Salsolidine ≥98% |
493-48-1 |
| 25 mg |
Inquiry |
| 100 mg |
Inquiry |
|
|
| LS-0047 |
Salsoline ≥98% |
89-31-6 |
| 25 mg |
Inquiry |
| 100 mg |
Inquiry |
|
|
| LS-0170 |
Sarafloxacin Hydrochloride 0.91 |
91296-87-6 |
| 5 g |
Inquiry |
| 10 g |
Inquiry |
| 25 g |
Inquiry |
|
|
| LS-0278 |
Satraplatin ≥98% |
129580-63-8 |
| 5 mg |
Inquiry |
| 10 mg |
Inquiry |
| 50 mg |
Inquiry |
|
|
| LS-0831 |
S-(-)-Schisandrin B ≥98% |
61281-37-6 |
| 5 mg |
Inquiry |
| 10 mg |
Inquiry |
|
|
| LS-0930 |
Schisantherin A ≥98% |
58546-56-8 |
| 5 mg |
Inquiry |
| 10 mg |
Inquiry |
|
|
| LS-1058 |
Scopolamine N-butylbromide ≥98% |
149-64-4 |
|
|
